Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itamar Raz

Showing results (171-180 of 254) with videos related to

Pageof 26
Sort By:
Journal of Inflammation Research|October 23, 2014
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus modelEhud Zigmond, Oshrat Tayer-Shifman, Gadi Lalazar, et al.
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
The International Journal of Lower Extremity Wounds|November 18, 2021
Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic TargetsDragos Serban, Nikolaos Papanas, Ana Maria Dascalu, et al.
Diabetes Care|October 1, 2015
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumWilliam T Cefalu, George A Bray, Philip D Home, et al.
The American Journal of Medicine|November 3, 2015
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1cMatthew A Cavender, Benjamin M Scirica, Itamar Raz, et al.
Eclinicalmedicine|October 8, 2021
Adolescent cognitive function and incident early-onset type 2 diabetesMiri Lutski, Inbar Zucker, Aya Bardugo, et al.
Diabetes Care|May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 TrialAvivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Research and Clinical Practice|March 30, 2018
The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help?Antonio Ceriello, James R Gavin, Andrew J M Boulton, et al.
Primary Care Diabetes|May 13, 2018
The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important?Kamlesh Khunti, James R Gavin, Andrew J M Boulton, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Semaglutide in MASLD Patients: Improved Survival and Liver OutcomesMohamad Suki, Johnny Amer, Yael Milgrom, et al.
Pageof 26

Showing results (171-180 of 254) with videos related to

Sort By:
Pageof 26
Journal of Inflammation Research|October 23, 2014
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus modelEhud Zigmond, Oshrat Tayer-Shifman, Gadi Lalazar, et al.
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
The International Journal of Lower Extremity Wounds|November 18, 2021
Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic TargetsDragos Serban, Nikolaos Papanas, Ana Maria Dascalu, et al.
Diabetes Care|October 1, 2015
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumWilliam T Cefalu, George A Bray, Philip D Home, et al.
The American Journal of Medicine|November 3, 2015
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1cMatthew A Cavender, Benjamin M Scirica, Itamar Raz, et al.
Eclinicalmedicine|October 8, 2021
Adolescent cognitive function and incident early-onset type 2 diabetesMiri Lutski, Inbar Zucker, Aya Bardugo, et al.
Diabetes Care|May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 TrialAvivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Research and Clinical Practice|March 30, 2018
The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help?Antonio Ceriello, James R Gavin, Andrew J M Boulton, et al.
Primary Care Diabetes|May 13, 2018
The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important?Kamlesh Khunti, James R Gavin, Andrew J M Boulton, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Semaglutide in MASLD Patients: Improved Survival and Liver OutcomesMohamad Suki, Johnny Amer, Yael Milgrom, et al.
Pageof 26